APOE ε4 influences medial temporalatrophy and tau deposition in atypical Alzheimer's disease

被引:12
|
作者
Singh, Neha Atulkumar [1 ]
Tosakulwong, Nirubol [2 ]
Graff-Radford, Jonathan [1 ]
Machulda, Mary M. [3 ]
Nha Trang Thu Pham [4 ]
Sintini, Irene [4 ]
Weigand, Stephen D. [2 ]
Schwarz, Christopher G. [4 ]
Senjem, Matthew L. [4 ]
Carrasquillo, Minerva M. [5 ]
Ertekin-Taner, Nilufer [5 ]
Jack, Clifford R., Jr. [4 ]
Lowe, Val J. [4 ]
Josephs, Keith A. [1 ]
Whitwell, Jennifer L. [4 ]
机构
[1] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Quantitat Hlth Sci, Rochester, MN 55905 USA
[3] Mayo Clin, Dept Psychiat & Psychol, Rochester, MN 55905 USA
[4] Mayo Clin, Dept Radiol, 200 1st St SW, Rochester, MN 55905 USA
[5] Mayo Clin, Dept Neurosci, Jacksonville, FL USA
基金
美国国家卫生研究院;
关键词
apolipoprotein epsilon 4; atypical Alzheimer's disease; logopenic progressive aphasia; posterior cortical atrophy; magnetic resonance imaging; tau positron emission tomography; POSTERIOR CORTICAL ATROPHY; CLINICAL PHENOTYPE; VARIANTS; ONSET; ASSOCIATION; AGE;
D O I
10.1002/alz.12711
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: Apolipoprotein E (APOE) epsilon 4 is an important genetic risk factor for typical Alzheimer's disease (AD), influencing brain volume and tau burden. Little is known about its influence in atypical presentations of AD. Methods: An atypical AD cohort of 140 patients diagnosed with either posterior cortical atrophy or logopenic progressive aphasia underwent magnetic resonance imaging and positron emission tomography. Linear mixed effects models were fit to assess the influence of APOE epsilon 4 on cross-sectional and longitudinal regional metrics. Results: At baseline, APOE epsilon 4 carriers had smaller hippocampal and amygdala volumes and greater tau standardized uptake volume ratio in the hippocampus and entorhinal cortex compared to non-carriers while longitudinally, APOE epsilon 4 non-carriers showed faster rates of atrophy and tau accumulation in the entorhinal cortex, with faster tau accumulation in the hippocampus. Discussion: APOE epsilon 4 influences patterns of neurodegeneration and tau deposition and was associated with more medial temporal involvement, although there is evidence that non-carriers may be catching up over time.
引用
收藏
页码:784 / 796
页数:13
相关论文
共 50 条
  • [21] ALZHEIMER DISEASE ApoE4 implicated in tau-mediated neurodegeneration
    Wood, Heather
    NATURE REVIEWS NEUROLOGY, 2017, 13 (12) : 706 - 706
  • [22] The Role of MicroRNAs in Aβ Deposition and Tau Phosphorylation in Alzheimer's Disease
    Zhao, Juanjuan
    Yue, Dongxu
    Zhou, Ya
    Jia, Li
    Wang, Hairong
    Guo, Mengmeng
    Xu, Hualin
    Chen, Chao
    Zhang, Jidong
    Xu, Lin
    FRONTIERS IN NEUROLOGY, 2017, 8
  • [23] Aerobic glycolysis and tau deposition in preclinical Alzheimer's disease
    Vlassenko, Andrei G.
    Gordon, Brian A.
    Goyal, Manu S.
    Su, Yi
    Blazey, Tyler M.
    Durbin, Tony J.
    Couture, Lars E.
    Christensen, Jon J.
    Jafri, Hussain
    Morris, John C.
    Raichle, Marcus E.
    Benzinger, Tammie L. -S.
    NEUROBIOLOGY OF AGING, 2018, 67 : 95 - 98
  • [24] Astrocytic tau deposition is frequent in Alzheimer disease and does not correlate with an atypical clinical presentation
    Nolan, Amber
    Resende, Elisa De Paula Franca
    Petersen, Cathrine
    Ehrenberg, Alexander
    Spina, Salvatore
    Seeley, William
    Grinberg, Lea T.
    LABORATORY INVESTIGATION, 2018, 98 : 663 - 664
  • [25] Astrocytic tau deposition is frequent in Alzheimer disease and does not correlate with an atypical clinical presentation
    Nolan, Amber
    Resende, Elisa De Paula Franca
    Petersen, Cathrine
    Ehrenberg, Alexander
    Spina, Salvatore
    Seeley, William
    Grinberg, Lea T.
    MODERN PATHOLOGY, 2018, 31 : 663 - 664
  • [26] Tau and the fractionated default mode network in atypical Alzheimer's disease
    Putcha, Deepti
    Eckbo, Ryan
    Katsumi, Yuta
    Dickerson, Bradford C.
    Touroutoglou, Alexandra
    Collins, Jessica A.
    BRAIN COMMUNICATIONS, 2022, 4 (02)
  • [27] APOE4 testing for Alzheimer's disease
    Karlawish, JHT
    Sachs, GA
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1997, 45 (09) : 1153 - 1154
  • [28] Proteins linking APOE ε4 with Alzheimer's disease
    Oveisgharan, Shahram
    Yu, Lei
    Lopes, Katia de Paiva
    Tasaki, Shinya
    Wang, Yanling
    Menon, Vilas
    Schneider, Julie A.
    Seyfried, Nicholas T.
    Bennett, David A.
    ALZHEIMERS & DEMENTIA, 2024, 20 (07) : 4499 - 4511
  • [29] The relationship between complement factor C3, APOE ε4, amyloid and tau in Alzheimer’s disease
    Luke W. Bonham
    Rahul S. Desikan
    Jennifer S. Yokoyama
    Acta Neuropathologica Communications, 4
  • [30] The relationship between complement factor C3, APOE ε4, amyloid and tau in Alzheimer's disease
    Bonham, Luke W.
    Desikan, Rahul S.
    Yokoyama, Jennifer S.
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2016, 4 : 65